Trial shows aspirin doesn’t help protect Type 2 diabetes patients from heart disease
CHICAGO A trial published last week in the Journal of the American Medical Association determined that low-dose aspirin as a primary prevention tool against heart disease was ineffective in patients with Type 2 diabetes.
The study followed 2,539 Japanese patients diagnosed with Type 2 diabetes from December 2002 through April 2008 who had no prior incidence of heart disease. A total of 68 heart-disease events occurred in the group taking low-dose aspirin, vs. 86 events among those not taking any aspirin therapy.
Accordingly, the authors of the study concluded that in patients with Type 2 diabetes, low-dose aspirin as a primary prevention did not reduce the risk of cardiovascular events.
The Center for Drug Evaluation and Research, in a consumer education post on its web site, states that low-dose aspirin has been shown to be helpful when used daily to lower the risk of heart attack, clot-related strokes and other blood flow problems, so long as consumers consult a healthcare professional to talk about the use of low-dose aspirin on a daily basis.
McNeil launches promotion tour for Tylenol Warming Liquid
BOSTON McNeil Consumer Healthcare on Friday announced a multi-city grassroots promotion tour promoting Tylenol Warming Liquid and offering passengers access to free taxi rides so they can warm up.
Already a success in New York passengers in Boston can now receive complimentary transportation in the Copley Square/Suffolk County and Brookline areas, the company stated. The program will soon be expanded to include Philadelphia and Washington, as well.
Tylenol Warming Taxis will pick up passengers outside select CVS/pharmacy locations from 12 p.m. through 8 p.m. Nov. 17 through Nov. 23.
Better Nutrition names Natrol’s My Favorite Multiple ‘People’s Choice’ for supplements
CHATSWORTH, Calif. Natrol’s My Favorite Multiple has been granted the “People’s Choice” award by Better Nutrition Magazine readers, Natrol announced Monday.
“As the name denotes, this ‘People’s Choice’ award confirms that Natrol My Favorite Multiple is indeed a favorite supplement for Better Nutrition Magazine readers,” stated Michael Yatcilla, Natrol’s vice president of research and development.